Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo

M. Huettinger, J. R. Corbett, W. J. Schneider, J. T. Willerson, M. S. Brown, J. L. Goldstein

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The low density lipoprotein (LDL) receptor mediates the cellular uptake of plasma lipoproteins that are derived from very low density lipoproteins (VLDL). Most of the functional LDL receptors in the body are located in the liver. Here, we describe a radionuclide scintiscanning technique that permits the measurement of LDL receptors in the livers of intact rabbits. 123I-labeled VLDL were administered intravenously, and scintigraphic images of the liver and heart were obtained at intervals thereafter. In seven normal rabbits, radioactivity in the liver increased prgressively between 1 and 20 min after injection, while radioactivity in the heart (reflecting that in plasma) decreased concomitantly. In Watanabe-heritable hyperlipidemic rabbits, which lack LDL receptors on a genetic basis, there was little uptake of 123I-labeled VLDL into the liver and little decrease in cardiac radioactivity during this interval. These findings demonstrate that the LDL receptor is necessary for the hepatic uptake of VLDL-derived lipoproteins in the rabbit. Two conditions that diminish hepatic LDL receptor activity, cholesterol-feeding and prolonged fasting, also reduced the uptake of 123I-labeled VLDL in the liver as measured by scintiscanning. The data suggest that radionuclide scintiscanning can be used as a noninvasive method to quantify the number of LDL receptors expressed in the liver in vivo.

Original languageEnglish (US)
Pages (from-to)7599-7603
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume81
Issue number23 I
DOIs
StatePublished - 1984

Fingerprint

LDL Receptors
Radioisotopes
VLDL Lipoproteins
Liver
Radioactivity
Rabbits
Lipoproteins
Fasting
Cholesterol
Injections

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo. / Huettinger, M.; Corbett, J. R.; Schneider, W. J.; Willerson, J. T.; Brown, M. S.; Goldstein, J. L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 81, No. 23 I, 1984, p. 7599-7603.

Research output: Contribution to journalArticle

@article{58a17b2956f6472ea5a61cecf2f86043,
title = "Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo",
abstract = "The low density lipoprotein (LDL) receptor mediates the cellular uptake of plasma lipoproteins that are derived from very low density lipoproteins (VLDL). Most of the functional LDL receptors in the body are located in the liver. Here, we describe a radionuclide scintiscanning technique that permits the measurement of LDL receptors in the livers of intact rabbits. 123I-labeled VLDL were administered intravenously, and scintigraphic images of the liver and heart were obtained at intervals thereafter. In seven normal rabbits, radioactivity in the liver increased prgressively between 1 and 20 min after injection, while radioactivity in the heart (reflecting that in plasma) decreased concomitantly. In Watanabe-heritable hyperlipidemic rabbits, which lack LDL receptors on a genetic basis, there was little uptake of 123I-labeled VLDL into the liver and little decrease in cardiac radioactivity during this interval. These findings demonstrate that the LDL receptor is necessary for the hepatic uptake of VLDL-derived lipoproteins in the rabbit. Two conditions that diminish hepatic LDL receptor activity, cholesterol-feeding and prolonged fasting, also reduced the uptake of 123I-labeled VLDL in the liver as measured by scintiscanning. The data suggest that radionuclide scintiscanning can be used as a noninvasive method to quantify the number of LDL receptors expressed in the liver in vivo.",
author = "M. Huettinger and Corbett, {J. R.} and Schneider, {W. J.} and Willerson, {J. T.} and Brown, {M. S.} and Goldstein, {J. L.}",
year = "1984",
doi = "10.1073/pnas.81.23.7599",
language = "English (US)",
volume = "81",
pages = "7599--7603",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "23 I",

}

TY - JOUR

T1 - Imaging of hepatic low density lipoprotein receptors by radionuclide scintiscanning in vivo

AU - Huettinger, M.

AU - Corbett, J. R.

AU - Schneider, W. J.

AU - Willerson, J. T.

AU - Brown, M. S.

AU - Goldstein, J. L.

PY - 1984

Y1 - 1984

N2 - The low density lipoprotein (LDL) receptor mediates the cellular uptake of plasma lipoproteins that are derived from very low density lipoproteins (VLDL). Most of the functional LDL receptors in the body are located in the liver. Here, we describe a radionuclide scintiscanning technique that permits the measurement of LDL receptors in the livers of intact rabbits. 123I-labeled VLDL were administered intravenously, and scintigraphic images of the liver and heart were obtained at intervals thereafter. In seven normal rabbits, radioactivity in the liver increased prgressively between 1 and 20 min after injection, while radioactivity in the heart (reflecting that in plasma) decreased concomitantly. In Watanabe-heritable hyperlipidemic rabbits, which lack LDL receptors on a genetic basis, there was little uptake of 123I-labeled VLDL into the liver and little decrease in cardiac radioactivity during this interval. These findings demonstrate that the LDL receptor is necessary for the hepatic uptake of VLDL-derived lipoproteins in the rabbit. Two conditions that diminish hepatic LDL receptor activity, cholesterol-feeding and prolonged fasting, also reduced the uptake of 123I-labeled VLDL in the liver as measured by scintiscanning. The data suggest that radionuclide scintiscanning can be used as a noninvasive method to quantify the number of LDL receptors expressed in the liver in vivo.

AB - The low density lipoprotein (LDL) receptor mediates the cellular uptake of plasma lipoproteins that are derived from very low density lipoproteins (VLDL). Most of the functional LDL receptors in the body are located in the liver. Here, we describe a radionuclide scintiscanning technique that permits the measurement of LDL receptors in the livers of intact rabbits. 123I-labeled VLDL were administered intravenously, and scintigraphic images of the liver and heart were obtained at intervals thereafter. In seven normal rabbits, radioactivity in the liver increased prgressively between 1 and 20 min after injection, while radioactivity in the heart (reflecting that in plasma) decreased concomitantly. In Watanabe-heritable hyperlipidemic rabbits, which lack LDL receptors on a genetic basis, there was little uptake of 123I-labeled VLDL into the liver and little decrease in cardiac radioactivity during this interval. These findings demonstrate that the LDL receptor is necessary for the hepatic uptake of VLDL-derived lipoproteins in the rabbit. Two conditions that diminish hepatic LDL receptor activity, cholesterol-feeding and prolonged fasting, also reduced the uptake of 123I-labeled VLDL in the liver as measured by scintiscanning. The data suggest that radionuclide scintiscanning can be used as a noninvasive method to quantify the number of LDL receptors expressed in the liver in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0021745305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021745305&partnerID=8YFLogxK

U2 - 10.1073/pnas.81.23.7599

DO - 10.1073/pnas.81.23.7599

M3 - Article

C2 - 6594702

AN - SCOPUS:0021745305

VL - 81

SP - 7599

EP - 7603

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 23 I

ER -